RankingsPricing
  1. JP-listed companies
  2. SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals LimitedJP:4582

Market cap
¥11.4B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Cash and deposits-----------6,2836,517
Accounts receivable - trade-----------2,085913
Merchandise and finished goods-----------294232
Semi-finished goods-----------175-
Supplies-----------00
Advance payments to suppliers-----------253272
Prepaid expenses-----------210119
Other-----------1330
Current assets-----------9,3138,083
Buildings, net-----------41-
Buildings-----------65237
Accumulated depreciation------------24-237
Buildings, net-----------41-
Tools, furniture and fixtures, net-----------28-
Tools, furniture and fixtures-----------73105
Accumulated depreciation------------45-105
Tools, furniture and fixtures, net-----------28-
Property, plant and equipment-----------69-
Software-----------222-
Intangible assets-----------222-
Deferred tax assets-----------745-
Leasehold and guarantee deposits-----------8588
Deferred tax assets-----------745-
Investments and other assets-----------82988
Leasehold and guarantee deposits-----------8588
Investments and other assets-----------82988
Non-current assets-----------1,12188
Assets-----------10,4338,170
Accounts payable - trade-----------47-
Accounts payable - other-----------1,164854
Income taxes payable-----------40118
Accounts payable - other-----------1,164854
Provision for office transfer expenses------------17
Income taxes payable-----------40118
Provision for merchandise and finished goods switching-----------16-
Other-----------29668
Provision for office transfer expenses------------17
Current liabilities-----------1,924957
Provision for merchandise and finished goods switching-----------16-
Other-----------29668
Current liabilities-----------1,924957
Retirement benefit liability-----------34
Non-current liabilities-----------34
Liabilities-----------1,927960
Share capital-----------17,54817,953
Capital surplus-----------17,52317,928
Capital surplus-----------17,52317,928
Retained earnings------------26,889-28,852
Retained earnings------------26,889-28,852
Treasury shares------------88-89
Shareholders' equity-----------8,0946,939
Share acquisition rights-----------412277
Foreign currency translation adjustment-----------0-6
Valuation and translation adjustments-----------0-6
Net assets----------6,7478,5067,210
Share acquisition rights-----------412277
Net assets----------6,7478,5067,210
Liabilities and net assets-----------10,4338,170